alphaXRT

alphaXRT is an Australia- and New Zealand-focused radiation oncology company that markets, sells, services, and supports equipment, software, accessories, and training used in the treatment of cancer. The company positions itself as a leading independent supplier of radiation oncology solutions in Australasia, covering treatment delivery, treatment planning, patient positioning, medical physics and QA, and radiation oncology education. Its business is commercial rather than drug-development oriented, with a portfolio built around distribution and support of advanced radiotherapy technologies from global suppliers. alphaXRT also participates in adjacent research and irradiation applications and has distributed novel modalities such as boron neutron capture therapy systems in the region. In 2025/2026, alphaXRT became part of the EBOS MedTech portfolio.